BB Biotech AG/€BION
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About BB Biotech AG
BB Biotech AG is an investment company that focuses on investments in the biotechnology industry. The company is headquartered in Schaffhausen, Switzerland, and specializes in managing a portfolio primarily composed of companies involved in the development of innovative drugs and therapies. It seeks to capture growth opportunities in the biotech sector by investing in firms with cutting-edge scientific research and promising product pipelines. BB Biotech AG's investment strategy is informed by an in-depth analysis of market trends and scientific advancements, ensuring a dynamic and diversified portfolio. Its geographic footprint is primarily in Europe, with strategic investments in biotech firms globally.
Ticker
€BION
Sector
Primary listing
XGAT
Employees
10
Headquarters
Küsnacht, Switzerland
BB Biotech AG Metrics
BasicAdvanced
€2.7bn
3.04
€15.87
-
€2.46
5.10%
Price and volume
Market cap
€2.7bn
52-week high
€53.60
52-week low
€29.86
Average daily volume
7.1k
Dividend rate
€2.46
Financial strength
Current ratio
336.028
Quick ratio
335.99
Dividend payout ratio (TTM)
15.56%
Profitability
Gross margin (TTM)
100.00%
Net profit margin (TTM)
129.58%
Operating margin (TTM)
94.67%
Effective tax rate (TTM)
0.01%
Revenue per employee (TTM)
€67,174,270
Management effectiveness
Return on assets (TTM)
15.87%
Return on equity (TTM)
34.85%
Valuation
Price to earnings (TTM)
3.038
Price to revenue (TTM)
3.936
Price to book
0.92
Price to tangible book (TTM)
0.92
Price to free cash flow (TTM)
6.155
Free cash flow yield (TTM)
16.25%
Free cash flow per share (TTM)
7.831
Dividend yield (TTM)
5.10%
Forward dividend yield
5.10%
Growth
Revenue change (TTM)
-870.58%
Earnings per share change (TTM)
-286.86%
3-year revenue growth (CAGR)
5,258.97%
10-year revenue growth (CAGR)
8.78%
3-year earnings per share growth (CAGR)
36.81%
10-year earnings per share growth (CAGR)
-1.42%
3-year dividend per share growth (CAGR)
-7.58%
10-year dividend per share growth (CAGR)
-2.51%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BB Biotech AG stock?
BB Biotech AG (BION) has a market cap of €2.7B as of May 02, 2026.
What is the P/E ratio for BB Biotech AG stock?
The price to earnings (P/E) ratio for BB Biotech AG (BION) stock is 3.04 as of May 02, 2026.
Does BB Biotech AG stock pay dividends?
Yes, the BB Biotech AG (BION) stock pays dividends to shareholders. As of May 02, 2026, the dividend rate is €2.45758 and the yield is 5.1%. BB Biotech AG has a payout ratio of 15.56% on a trailing twelve-month basis.
When is the next BB Biotech AG dividend payment date?
The next BB Biotech AG (BION) dividend payment date is unconfirmed.
What is the beta indicator for BB Biotech AG?
BB Biotech AG (BION) does not currently have a Beta indicator.